Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Palatin Technologies, Inc. (PTN : AMEX)

• Company Description    Palatin Technologies, Inc is a development-stage medical technology companyinvolved in developing and commercializing products and technologies fordiagnostic imaging, cancer therapy and ethical drug development These developments are based on its proprietary monoclonal antibody radiolabeling and enabling peptide platform technologies. Number of Employees: 29

• Price / Volume Information    Yesterday's Closing Price: $19.35 Daily Weekly Monthly 20 Day Moving Average: 23,088 shares Shares Outstanding: 1.77 (millions) Market Capitalization: $34.29 (millions) Beta: 0.46 52 Week High: $52.50 52 Week Low: $4.10 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 18.64% 18.54% 12 Week 13.96% 12.82% Year To Date 25.81% 25.16%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 301 CARNEGIE CENTER DRIVE SUITE 304 - PRINCETON,NJ 08540 USA ph: 609-495-2200 fax: 609-495-2202 investors@palatin.com http://www.palatin.com

• General Corporate Information    Officers Carl Spana - Chief Executive Officer; President and Director John K. A. Prendergast - Chairperson and Director Stephen T. Wills - Executive Vice President; Chief Financial Officer Alan W. Dunton - Director Arlene M. Morris - Director Peer Information Palatin Technologies, Inc. (CORR.) Palatin Technologies, Inc. (RSPI) Palatin Technologies, Inc. (CGXP) Palatin Technologies, Inc. (BGEN) Palatin Technologies, Inc. (GTBP) Palatin Technologies, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 696077601 SIC: 2834 Fiscal Year Fiscal Year End: June Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/13/26 Share - Related Items Shares Outstanding: 1.77 Most Recent Split Date: 8.00 (0.02:1) Beta: 0.46 Market Capitalization: $34.29 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.87 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 52.33% vs. Previous Quarter: -167.14% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -98.69% ROE 12/31/25 - -5,516.91 09/30/25 - - 06/30/25 - - ROA 12/31/25 - -114.82 09/30/25 - -96.49 06/30/25 - -470.30 Current Ratio 12/31/25 - 2.76 09/30/25 - 1.02 06/30/25 - 0.36 Quick Ratio 12/31/25 - - 09/30/25 - 1.02 06/30/25 - 0.36 Operating Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Net Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Pre-Tax Margin 12/31/25 - -107.40 09/30/25 - -54.31 06/30/25 - - Book Value 12/31/25 - 6.47 09/30/25 - 0.41 06/30/25 - -4.94 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - 0.00 09/30/25 - 0.00 06/30/25 - - Debt-to-Capital 12/31/25 - 0.00 09/30/25 - 0.00 06/30/25 - -

Powered by Zacks Investment Research ©